Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βPhase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumorsβ.
Farshid Dayyani, David Sommerhalder, Andrae Lavon Vandross, Meredith S. Pelster, Jason T. Henry +9 more